Form D · Pharmaceuticals
PaxVax, Inc.
Redwood City, CA · CIK 0001402296
Offering snapshot reported Aug 11, 2014 · SEC filing
- Reported sold
- $34.9M Offering amount: $35.5M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 2, 2013 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$22,745,849 → $34,929,181
- Reported investors8 → 9
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 11, 2014 | Amendment | $34,929,181 | $12,183,332vs Dec 17, 2013 | 9 | SEC filing |
| Apr 18, 2014 | Initial | $6,000,000 | No comparison | 2 | SEC filing |
| Dec 17, 2013 | Initial | $22,745,849 | No comparison | 8 | SEC filing |
| Oct 31, 2013 | Initial | $2,500,000 | No comparison | 2 | SEC filing |
| Oct 1, 2013 | Amendment | $35,106,472 | $10,809,597vs Nov 24, 2010 | 19 | SEC filing |
| Nov 24, 2010 | Initial | $24,296,875 | No comparison | 4 | SEC filing |
| Nov 6, 2009 | Initial | $2,000,000 | No comparison | 2 | SEC filing |
| Jun 1, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-208080
Common Stock and Series B Preferred Stock and the Common Stock issuable upon conversion thereof
Source: Form D, filed Aug 11, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rennie Coit | Director |
| Henry G. Coit, Jr. | Director |
| James Connolly | Director |
| Kenneth J. Kelley | Director, Executive |
| Howard B. Rosen | Director |
| Phil Russell | Director |
| Janine M. Taylor | Executive |
| Richard Tong | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
900 Veterans Boulevard Suite 500
Redwood City, CA, 94063
Redwood City, CA, 94063